In the Brief Report titled “Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial,” published online July 1, 2021, and also in the August 2021 print issue of JAMA Oncology,1 Katherine M. Moxley, MD, was erroneously included in the byline, and Sagila George, MD, was mistakenly excluded. This article has been corrected online, and the Author Contributions section has been amended accordingly.1
References
- 1.Rahma OE, Yothers G, Hong TS, et al. Use of total neoadjuvant therapy for locally advanced rectal cancer: initial results from the pembrolizumab arm of a phase 2 randomized clinical trial. JAMA Oncol. 2021;7(8):1225-1230. doi: 10.1001/jamaoncol.2021.1683 [DOI] [PMC free article] [PubMed] [Google Scholar]